A sensitive flow cytometry method for anti-GM1 antibodies detection

Journal of Neuroimmunology

Volumn 125, Issue 1-2, 2002, Pages 163-169

  Escande Beillard, Nathalie ^a   David, Marie J ^b   Portoukalian, Jacques ^c   Pouget, Jean ^d   Azulay, Jean P ^d   Bernard, Dominique ^a   Boucraut, José ^a  

^a Mediterranée University   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Tumor Glycobiology Laboratory   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

Flow cytometry; GM1; Multifocal motor neuropathy

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CELL LINE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MOTOR NEURON DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

AUTOANTIBODIES; FLOW CYTOMETRY; G(M1) GANGLIOSIDE; GLIOBLASTOMA; HUMANS; MOTOR NEURON DISEASE; NEUROBLASTOMA; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0036224402     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00028-0     Document Type: Article

References (37)

1. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: A study of 180 sera
2. Detection of anti-GM1 ganglioside antibodies in patients with neuropathy by a novel latex agglutination assay
3. The natural autoantibodies system: Between hypotheses and facts
4. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study
5. Long term follow up of multifocal motor neuropathy with conduction block under treatment
6. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy
7. Cryptogenic partial epilepsies with anti-GM1 antibodies: A new form of immune-mediated epilepsy?
8. Multifocal motor neuropathy mimicking motor neuron disease: Nine cases
9. Anti-GM2 IgM antibodies: Clinical correlates and reactivity with a human neuroblastoma cell line
10. Axonal Guillain-Barre syndrome: A critical review
11. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE
12. Modification of ganglioside GM1: Effect of lipid moiety on choleragen action
13. Cell calcium signaling via GM1 cell surface gangliosides in the human Jurkat T cell line
14. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis
15. Signal transduction through glyco(sphingo)lipids: Introduction and recent studies on glyco(sphingo)lipid-enriched microdomains
16. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons
17. Gangliosides inhibit growth factor-stimulated neurite outgrowth in SH-SY5Y human neuroblastoma cells
18. Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1
19. The clinical correlates of high-titer IgG anti-GM1 antibodies
20. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: II. Modulatory effects of gangliosides
21. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas
22. Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system
23. Intracellular distribution of a biotin-labeled ganglioside, GM1, by immuno-electron microscopy after endocytosis in fibroblasts
24. Monoclonal antibody to galactosylceramide: Discrimination of structural difference in the ceramide moiety
25. Rapid internalization of exogenous ganglioside GM3 and its metabolism to ceramide in human myelogenous leukemia HL-60 cells compared with control ganglioside GM1
26. Multifocal motor neuropathy
27. Consensus criteria for the diagnosis of partial conduction block
28. Time and temperature dependent aggregation behaviour of the ganglioside GM1 in aqueous solution
29. Multifocal motor neuropathy: Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates
30. Multifocal motor neuropathy: Serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone
31. A review and predictive models of ganglioside uptake by biological membranes
32. The distribution of ganglioside-like moieties in peripheral nerves
33. The effect of anti-GM1 antibodies on ionic channel in myelinated nerve
34. Gangliosides turnover and neural cells function: A new perspective
35. Ganglioside GM1 activates the mitogen-activated protein kinase Erk2 and p70 S6 kinase in U-1242 MG human glioma cells
36. Inflammatory neuropathies - Pathogenesis and the role of intravenous immune globulin
37. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies